The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include Piroxicam Glaxo, Dolonex, Felden, and Piroxicam Pfizer. The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.

Read more:
https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2018

The global musculoskeletal drugs market has shown high growth in the past years with a CAGR of over 7.3%. The year 2017 recorded a net market value of $130 billion as per TBRC’s in-house consultants.
TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.

The report also shows the global musculoskeletal drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.

Sample report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=278&type=smp

Topical NSAIDs are being used for treatment of acute musculoskeletal pain in adults. A NSAID penetrates the skin, enters tissues or joints, and reduces processes causing pain in the tissue. It can be used as a gel, cream, spray, or plaster to unbroken skin with musculoskeletal pain. Topical NSAIDs also leads to very low level of drug in the blood as compared to oral drugs, thus, minimizing the risk of harmful effects. In June 2015, medical research organization Cochrane published the results of its clinical trials to compare topical NSAIDs with placebo or other medicines in patients above 16 years with musculoskeletal pain. These results indicate that gel formulations of NSAIDs diclofenac and ketoprofen were more effective in treatment of strain, sprain, or muscle pull, as compared to placebo

Request for Discount: https://www.thebusinessresearchcompany.com/sample.aspx?id=278&type=discount

Companies included in the report are F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc., Abbott Laboratories Inc., and Daiichi Sankyo Company, Limited.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company